News

According to Teva, Effexor has annual sales of approximately $152 million. The Israeli company said that it would begin to ship its generic version of the product immediately.

The Tissue Banking and Analysis Center (TBAC), in collaboration with US Oncology and AmeriPath, one of the largest networks of pathologists engaged in cancer diagnosis, will provide unprecedented

Under the agreements, Bio-Connect has gained exclusive rights to sell protein kinases in Germany, the UK, France, the Netherlands, Belgium and Luxembourg, and KinaseDetect has gained the rights

The product, HCV-IET, combines Transition’s interferon enhancer, EMZ702, with the current standard of care for hepatitis C, a combination therapy of pegylated interferon alpha and ribavirin. The study

Eisai said that it believes that its patent covering the composition of donepezil, the active ingredient in Aricept, is valid until its expiration date of November 25, 2010,

As part of the agreement, Biogen Idec has acquired an option to the exclusive worldwide rights to develop and commercialize therapeutics for the treatment of amyotrophic lateral sclerosis

Galapagos will collaborate with AstraZeneca via its service division BioFocus DPI. Under the terms of the agreement, BioFocus DPI will perform hit-to-lead medicinal chemistry services for AstraZeneca’s respiratory

Under the terms of the amended agreement, Predix may be eligible for up to an additional $3.5 million in research funding and milestone payments, bringing the total value

The randomization of 120 volunteer subjects with stable essential hypertension at 16 clinical centers in the US was initiated in May this year, and results are anticipated in